These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 2871214

  • 1. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM, Lopez PF, Parks WP, Paul RD.
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Induction of "innocent bystander" cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt-1+2- mammary tumor immune T-cells.
    Paul RD, Lopez DM.
    Cancer Res; 1987 Feb 15; 47(4):1105-10. PubMed ID: 2879623
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD, Padmanabhan R, Lopez DM.
    Cancer Res; 1984 Oct 15; 44(10):4480-6. PubMed ID: 6467207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An antigen cross-reactive with gp52 of mammary tumor virus is expressed on a B cell subpopulation of mice.
    Tax A, Ewert D, Manson LA.
    J Immunol; 1983 May 15; 130(5):2368-71. PubMed ID: 6300244
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of acquired provirus sequences in mammary tumors from low-expressor, low-risk mice.
    Altrock BW, Cardiff RD, Puma JP, Lund JK.
    J Natl Cancer Inst; 1982 Jun 15; 68(6):1037-41. PubMed ID: 6283224
    [Abstract] [Full Text] [Related]

  • 15. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
    Lopez DM, Charyulu V, Sigel MM.
    Cancer Res; 1981 Mar 15; 41(3):813-8. PubMed ID: 6257384
    [Abstract] [Full Text] [Related]

  • 16. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development.
    Altrock BW, Cardiff RD, Blair PB.
    J Natl Cancer Inst; 1981 Jul 15; 67(1):163-8. PubMed ID: 6265680
    [Abstract] [Full Text] [Related]

  • 17. Immunization of mice against murine mammary tumor virus infection and mammary tumor development.
    Sarkar NH, Moore DH.
    Cancer Res; 1978 May 15; 38(5):1468-72. PubMed ID: 205366
    [Abstract] [Full Text] [Related]

  • 18. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM, Smith BA, Stolfi RL, Martin DS.
    Cancer Res; 1981 Oct 15; 41(10):3885-90. PubMed ID: 6269731
    [Abstract] [Full Text] [Related]

  • 19. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice.
    Buessow SC, Paul RD, Lopez DM.
    J Natl Cancer Inst; 1984 Jul 15; 73(1):249-55. PubMed ID: 6610791
    [Abstract] [Full Text] [Related]

  • 20. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB, Lane MA.
    J Immunol; 1975 Jan 15; 114(1 Pt 1):17-23. PubMed ID: 163276
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.